Clinical Trials & Real World Data

Clinical trials & real world data

The demands on effectiveness, safety and quality of drugs and treatments are increasing year by year. Real World Data are health data collected under real conditions in hospitals cooperating with us. We support pharmaceutical companies and manufacturers of medical devices to obtain valuable additional information through the Real World Data approach.

The benefits range from identifying and evaluating the safety and effectiveness of the product to estimating the costs of certain diseases and treatments and risk-benefit assessments for specific groups of people. For example, during the regulated approval process, the Chinese regulatory authorities determine products whose safety has not been tested in Chinese persons as "partially acceptable" and require further studies. When planning market launches, particularly in China, the collection of real world data is therefore an essential part of the approval process. In this way, in addition to random clinical trials, pragmatic results can speed up the process, reduce approval costs and cut time-to-market to a fraction.